ISRCTN50142667已完成2 期
Minimally invasive surgery plus rt-PA for ICH evacuation
Johns Hopkins University (USA)0 个研究点目标入组 141 人开始时间: 2010年4月29日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 141
研究概览
简要总结
2013 results in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124642 (added 10/09/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18 - 80 years, either sex
- •2. Glasgow Coma Scale (GCS) less than 14 or a National Institutes of Health Stroke Scale (NIHSS) (including the use of distal hand measures) greater than 6
- •3. Spontaneous supratentorial ICH greater than 20 cc
- •4. Symptoms less than 12 hours prior to diagnostic CT scan (an unknown time of symptom onset is exclusionary)
- •5. Intention to initiate surgery within 48 hours after diagnostic CT
- •6. First dose can be given within 54 hours of diagnostic CT
- •7. Six-hour clot size equal to the most previous clot size + 5 cc (as determined by additional CT scan at least 6 hours after the initial stability scan (A*B*C)/2 method)
- •8. Systolic blood pressure (SBP) less than 200 mmHg sustained for 6 hours recorded closest to the time of randomisation
- •9. Historical Rankin score of 0 or 1
- •10. Negative pregnancy test
排除标准
- •1. Infratentorial hemorrhage including brainstem (any involvement of the midbrain or lower brainstem as demonstrated by radiograph or complete third nerve palsy)
- •2. Patients with platelet count less than 100,000, international normalised ratio (INR) greater than 1.7, or an elevated prothrombin time (PT) or activated partial thromboplastin time (APTT) (reversal of coumadin is permitted but the patient must not require coumadin during the acute hospitalisation). Irreversible coagulopathy either due to medical condition or prior to randomiation (patient must have a sustained INR less than 1.7 using short- and long-acting procoagulants [Novoseven, FFP, and/or vitamin K]).
- •3. Clotting disorders
- •4. Any concurrent serious illness that would interfere with the safety assessments including hepatic, renal, gastroenteroligic, respiratory, cardiovascular, endocrinologic, immunologic, and haematologic disease
- •5. Patients with a mechanical valve
- •6. Patients with unstable mass or evolving intracranial compartment syndrome
- •7. Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly
- •8. Greater than 80 years (higher incidence of amyloid)
- •9. Under 18 years of age (high incidence of occult vascular malformation)
- •10. Pregnant (positive pregnancy test) or lactating females (likelihood of altered coagulation function associated with the high oestrogen/progesterone state)
- •11. Irreversibly impaired brainstem function (bilateral fixed, dilated pupils and extensor motor posturing), GCS less than or equal to 4
- •12. Historical Rankin score greater than or equal to 2
- •13. Intraventricular haemorrhage requiring external ventricular drainage
- •14. Internal bleeding, involving retroperitoneal sites, or the gastrointestinal, genitourinary, or respiratory tracts
- •15. Superficial or surface bleeding, observed mainly at vascular puncture and access sites (e.g., venous cutdowns, arterial punctures) or site of recent surgical intervention
- •16. Known risk for embolisation, including history of left heart thrombus, mitral stenosis with atrial fibrillation, acute pericarditis, and subacute bacterial endocarditis
- •17. In the investigator's opinion, the patient is unstable and would benefit from a specific intervention rather than supportive care plus or minus endoscopic or MIS+rtPA
- •18. Prior enrolment in the study
- •19. Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated
- •20. Participation in another simultaneous trial of ICH treatment
研究者
相似试验
已完成
3 期
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase IIIIntracerebral HemorrhageNCT01827046Johns Hopkins University499
进行中（未招募）
不适用
Minimally Invasive Surgery plus rt-PA for ICH Evacuation - MISTIEEUCTR2007-006006-22-GBewcastle upon Tyne Hospitals NHS Trust130
进行中（未招募）
不适用
Minimally Invasive Surgery plus rt-PA for ICH Evacuation,MISTIE - MISTIEThe purpose of this trial is to determine the safety of using either endoscopic surgery or a combination of minimally invasive surgery and clot lysis with rt-PA to remove ICHMedDRA version: 12.1Level: LLTClassification code 10022753Term: Intracerebral haemorrhageEUCTR2007-006006-22-DEJohns Hopkins University, Department of Neurology130
进行中（未招募）
不适用
MIST Versus M-MIST for the Treatment of Intrabony DefectsIntrabony Periodontal DefectPeriodontitis, ChronicPeriodontitisNCT06058923University of Campinas, Brazil50
已完成
2 期
Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage EvacuationIntracerebral HemorrhageNCT00224770Daniel Hanley141